Originator Organization Umoja Biopharma, Inc.StartupTreeFrog Therapeutics SASStartup |
Active Organization Umoja Biopharma, Inc.StartupTreeFrog Therapeutics SASStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | Umoja Biopharma, Inc.Startup | 10 Jun 2022 |
Neoplasms | Preclinical | FR | TreeFrog Therapeutics SASStartup | 10 Jun 2022 |